CovidVax show full list

VAAST Oral Vaccine platform

Vaxart + Emergent BioSolutions + KindredBio
vaccine type: Non-replicating viral vector
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)



started September 24 2020

with 48 healthy volunteers aged 18-54

trial location: USA

» clinical trial details

Oct 13Vaxart announced that the first subject has been dosed with the vaccine in its Phase 1 clinical trial (by
Sep 14U.S. FDA gave clearance of IND application for Vaxart's vaccine which will start Phase 1 trials this month (by
Apr 21Vaxart expects to start clinical trials for its vaccine in the second half of 2020 (by
Animal Testing updates (pre-clinical trials)
start date: April 2020
Sep 08Vaxart's oral vaccine induced potent systemic and mucosal immune responses in preclinical studies (by
Apr 21Vaxart vaccine pre-clinical tests generated immune responses in all tested animals (by
early development updates
Mar 31Vaxart have produced 5 vaccine candidates for testing in its pre-clinical trials (by

May 20Vaxart has contracted with KindredBio to manufacture its lead vaccine candidate at a large scale (by
Mar 18Vaxart partners with Emergent to develop an oral recombinant vaccine candidate (by

contact | about | ©2020 project